PURB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.280400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.324400E-01
Normal-vs-Stage2
6.395800E-01
Normal-vs-Stage3
6.217600E-02
Normal-vs-Stage4
6.225000E-01
Stage1-vs-Stage2
9.625400E-01
Stage1-vs-Stage3
3.430100E-02
Stage1-vs-Stage4
2.656000E-01
Stage2-vs-Stage3
3.364100E-02
Stage2-vs-Stage4
1.297440E-01
Stage3-vs-Stage4
4.476000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.150600E-01
Normal-vs-AfricanAmerican
9.243400E-01
Normal-vs-Asian
5.305600E-01
Caucasian-vs-AfricanAmerican
5.962200E-01
Caucasian-vs-Asian
4.656000E-01
AfricanAmerican-vs-Asian
4.721600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.846000E-01
Normal-vs-Female
7.068800E-01
Male-vs-Female
4.782800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.687400E-01
Normal-vs-Age(41-60Yrs)
8.462200E-01
Normal-vs-Age(61-80Yrs)
4.353800E-01
Normal-vs-Age(81-100Yrs)
3.271600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.960000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.941340E-03
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.851620E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.822800E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.879600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.908800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.218600E-01
Normal-vs-Daily Drinker
3.557400E-01
Normal-vs-Weekly Drinker
7.304400E-01
Normal-vs-Occasional Drinker
9.501000E-01
Normal-vs-Social Drinker
6.385600E-01
Non Drinker-vs-Daily Drinker
8.670400E-01
Non Drinker-vs-Weekly Drinker
3.708200E-01
Non Drinker-vs-Occasional Drinker
5.422400E-02
Non Drinker-vs-Social Drinker
6.915600E-03
Daily Drinker-vs-Weekly Drinker
3.706800E-01
Daily Drinker-vs-Occasional Drinker
6.948400E-02
Daily Drinker-vs-Social Drinker
1.388230E-02
Weekly Drinker-vs-Occasional Drinker
5.325000E-01
Weekly Drinker-vs-Social Drinker
1.760010E-01
Occasional Drinker-vs-Social Drinker
2.827800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.048400E-01
Normal-vs-Grade 2
8.014800E-01
Normal-vs-Grade 3
7.085600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.690800E-01
Grade 1-vs-Grade 3
1.381390E-01
Grade 1-vs-Grade 4
8.048400E-01
Grade 2-vs-Grade 3
2.232100E-02
Grade 2-vs-Grade 4
8.014800E-01
Grade 3-vs-Grade 4
7.085600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.337200E-01
Normal-vs-NonDiabetic
6.895400E-01
Diabetic-vs-NonDiabetic
8.083800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.039200E-01
Normal-vs-NoPancreatitis
5.788200E-01
Pancreatitis-vs-NoPancreatitis
7.560600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.705200E-01
Normal-vs-N1
7.056800E-01
N0-vs-N1
2.137000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.329200E-01
Normal-vs-TP53-NonMutant
8.132000E-01
TP53-Mutant-vs-TP53-NonMutant
5.447800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
